Anika Therapeutics | ANIK - Trade Debtors


Anika Therapeutics reported $29.33M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Abbott USD 10.57B 171M Dec/2025
Agenus USD 22.44M 1.14M Dec/2025
Agios Pharmaceuticals USD 16.13M 5.56M Mar/2026
Anika Therapeutics USD 29.33M 661K Dec/2025
Arrowhead Research USD 15.68M 203.19M Mar/2026
Enanta Pharmaceuticals USD 40.16M 1.52M Dec/2024
Halozyme Therapeutics USD 457.99M 16.72M Mar/2026
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Insmed USD 178.55M 37.7M Mar/2026
Integra LifeSciences USD 264.41M 14.44M Mar/2026
Intrexon USD 1.02M 559K Jun/2024
J&J USD 21.33B 3.72B Dec/2025
Karyopharm Therapeutics USD 26.18M 5.6M Dec/2025
Ligand Pharmaceuticals USD 54.8M 6.25M Mar/2026
MacroGenics USD 10.42M 2.95M Mar/2026
Merit Medical Systems USD 227M 3.39M Mar/2026
Rigel Pharmaceuticals USD 28.9M 1.39M Jun/2024
Sangamo BioSciences USD 581K 110K Jun/2024
Sanofi EUR 482M 85M Mar/2026
Smith & Nephew USD 1.48B 85M Dec/2025
Stryker USD 3.57B 468M Mar/2026
Veracyte USD 50.11M 5.45M Mar/2026
Xencor USD 12M 17.3M Mar/2026
Zimmer Biomet Holdings USD 1.73B 24.2M Mar/2026